| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 1.12 |
—
—
—
|
| 2025 | 1.77 |
—
—
—
—
|
| 2024 | 1.81 |
—
—
—
—
|
| 2023 | 1.42 |
—
—
—
|
| 2022 | 2.29 |
—
—
—
—
|
| 2021 | 3.60 |
—
—
—
—
|
| 2020 | 1.75 |
—
—
—
—
|
| 2019 | 2.07 |
—
—
—
—
|
| 2018 | 3.32 |
—
—
—
—
—
|
| 2017 | 2.83 |
—
—
—
—
—
—
—
|
| 2016 | 2.24 |
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 14,459.24 | 10,687.10 | 11,079.87 | 10,159.09 |
| Receivables | 10,200.42 | 9,157.97 | 9,173.26 | 10,890.28 |
| Inventory | 11,645.94 | 9,925.42 | 9,617.55 | 9,777.44 |
| Other | 754.37 | 649.21 | 624.56 | 823.99 |
| 37,385.51 | 30,845.82 | 30,509.36 | 31,656.59 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 4,626.26 | 4,311.39 | 3,574.85 | 3,860.31 |
| ST’ Debt | — | — | — | — |
| Other | 4,211.77 | 3,580.93 | 3,933.28 | 4,136.63 |
| 17,974.19 | 15,918.74 | 16,149.46 | 15,964.83 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 12,513.27 | 13,481.08 | — | — |
—
|
| ’25 | 12,205.74 | 12,288.91 | 12,082.73 | 11,713.47 |
48,290.86
|
| ’24 | 14,441.56 | 12,956.78 | 12,824.96 | 11,198.29 |
51,421.59
|
| ’23 | 15,504.70 | 16,097.10 | 15,168.67 | 14,874.77 |
61,645.24
|
| ’22 | 17,070.46 | 18,408.04 | 14,808.17 | 26,216.58 |
76,503.26
|
| ’21 | 14,461.85 | 16,463.22 | 18,573.20 | 18,910.02 |
68,408.28
|
| ’20 | 11,636.65 | 10,977.24 | 11,408.97 | 11,950.47 |
45,973.34
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (251.51) | 747.54 | — | — |
—
|
| ’25 | 468.15 | 1,234.79 | 156.63 | 1,340.77 |
3,200.34
|
| ’24 | 228.11 | 1,924.84 | 936.74 | 1,574.87 |
4,664.56
|
| ’23 | (216.71) | 1,916.92 | 1,723.47 | 1,510.48 |
4,934.16
|
| ’22 | 7.53 | 219.39 | 1,888.95 | 3,452.22 |
5,568.09
|
| ’21 | 513.78 | 1,479.82 | 1,433.71 | 2,206.12 |
5,633.43
|
| ’20 | 1,380.26 | 1,700.03 | 1,709.45 | 2,158.85 |
6,948.59
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (987.37) | (106.71) | — | — |
—
|
| ’25 | (590.65) | 187.90 | (655.07) | 44.75 |
(1,013.06)
|
| ’24 | (1,305.00) | 702.29 | (446.54) | 39.20 |
(1,010.05)
|
| ’23 | (1,364.50) | 556.67 | 389.69 | (405.10) |
(823.23)
|
| ’22 | (763.93) | (646.50) | 1,342.46 | 765.39 |
697.43
|
| ’21 | (9.68) | 791.94 | 706.39 | 993.58 |
2,482.22
|
| ’20 | 565.13 | 1,100.90 | 1,227.20 | 1,320.51 |
4,213.73
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.01 | 1.30 | — | — |
—
|
| ’25 | 0.64 | 0.35 | 0.94 | (0.61) |
1.43
|
| ’24 | 1.22 | 1.14 | 1.01 | (1.19) |
2.10
|
| ’23 | 2.17 | 1.73 | 1.38 | (0.52) |
4.29
|
| ’22 | 4.49 | 3.86 | 1.46 | 1.79 |
9.09
|
| ’21 | 3.03 | 4.90 | 7.10 | 3.86 |
18.64
|
| ’20 | 1.03 | 0.10 | 1.17 | 2.00 |
4.27
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 36.53 | 53.12 | 42.74 | 39.40 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 65.11 | 133.09 | 93.19 | 61.24 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38,175 | 44,501 | 44,502 | 42,873 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.00 | 1.39 | 1.16 | 1.13 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 76,503.26 | 61,645.24 | 51,421.59 | 48,290.86 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.04% | 8.33% | 7.47% | 7.45% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,642.74 | 2,108.34 | 928.36 | 797.41 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.76% | 3.42% | 1.81% | 1.65% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,227.36 | 1,476.85 | 703.69 | 368.92 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,324.22 | 3,075.72 | 2,789.12 | 2,911.46 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 252.27 | 203.13 | 169.67 | 159.65 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 9.09 | 4.29 | 2.10 | 1.43 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.36 | 16.26 | 15.39 | 10.58 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (16.06) | (18.97) | (18.72) | (13.93) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.30 | (2.71) | (3.33) | (3.35) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 172.70 | 157.11 | 141.91 | 144.39 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 303.26 | 303.48 | 303.07 | 302.48 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.41 | 19.39 | 19.89 | 40.31 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.21 | 0.45 | 0.26 | 0.33 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.31 | 0.59 | 0.31 | 0.37 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.26 | 0.56 | 0.43 | 0.52 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.48 | (42.10) | (21.76) | (24.63) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,568.09 | 4,934.16 | 4,664.56 | 3,200.34 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4,870.66) | (5,757.39) | (5,674.61) | (4,213.40) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 697.43 | (823.23) | (1,010.05) | (1,013.06) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22,327.51 | 19,411.32 | 14,927.08 | 14,359.90 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20,725.18 | 12,008.93 | 10,417.13 | 11,462.21 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,658.46 | (2,450.31) | (269.97) | 382.34 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 52,372.71 | 47,678.88 | 43,009.94 | 43,674.90 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.30% | 1.60% | 1.03% | 0.66% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.36% | 3.03% | 1.49% | 1.47% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.59% | 2.72% | 1.74% | 1.12% | — | — | — |
ROE
|
POSCO International (PKX), South Korea’s steel powerhouse, embodies the savage volatility of global commodity cycles, with revenue surging 156% from $47.6 billion in 2016 to a 2022 peak of $76.5 billion before plunging 33% to $51.4 billion in 2024—mirroring steel price booms from post-COVID infrastructure spending and supply snarls, followed by China’s oversupply glut. Profitability has eroded sharply, with gross margins halving from 15.6% to 7.5%, EBT margins to 1.8%, and ROE crashing 87% to 1.7%, hammered by energy shocks like the Ukraine war and persistent cost inflation in iron ore and coal.
Yet resilience shines through a fortified balance sheet: net debt flipped to a $270 million cash surplus (down 96% from 2016 peaks), total debt shed 47%, and book value per share rose 10% amid heavy capex—up 162% to $5.67 billion—for hydrogen steel plants and U.S. battery materials, positioning POSCO for EV and net-zero tailwinds despite free cash flow turning negative. Valuation screams opportunity at 0.31x book and 0.26x sales, though trailing PE at 19.9x reflects earnings pain; analysts eye 18% upside (highs to 94%), fueled by potential U.S. CHIPS Act demand and EU carbon taxes favoring efficient producers.
Risks persist from Chinese dumping, EV slowdowns, and tariffs, but with insiders silent and steel at multi-year troughs (ROA 1.0%), this coiled spring offers mean reversion potential for patient macro investors—read the full analysis for cycle parallels, insider voids, and Q1 2026 triggers.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.